Avinger to Announce Second Quarter 2024 Results on August 8, 2024
Avinger Inc. (Nasdaq: AVGR), a commercial-stage medical device company, has announced it will release its second quarter 2024 financial results on August 8, 2024, after the close of trading. The company will host a conference call at 1:30pm PT/4:30pm ET on the same day. Investors can join the call by dialing +1-848-280-6550 and using the passcode 'Avinger'. A live webcast will be available on the company's investor relations page, and a replay will be posted shortly after the call concludes.
Avinger specializes in marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of vascular disease.
Avinger Inc. (Nasdaq: AVGR), un'azienda di dispositivi medici in fase commerciale, ha annunciato che rilascerà i suoi risultati finanziari del secondo trimestre 2024 il 8 agosto 2024, dopo la chiusura delle contrattazioni. L'azienda ospiterà una teleconferenza alle 1:30pm PT/4:30pm ET dello stesso giorno. Gli investitori possono partecipare alla chiamata componendo il numero +1-848-280-6550 e utilizzando il codice di accesso 'Avinger'. Una diretta web sarà disponibile sulla pagina delle relazioni con gli investitori dell'azienda, e una registrazione sarà pubblicata subito dopo la conclusione della chiamata.
Avinger è specializzata nel commercializzare il primo e unico sistema basato su catetere guidato da immagini intravascolari per la diagnosi e il trattamento delle malattie vascolari.
Avinger Inc. (Nasdaq: AVGR), una empresa de dispositivos médicos en fase comercial, ha anunciado que publicará sus resultados financieros del segundo trimestre de 2024 el 8 de agosto de 2024, después del cierre del mercado. La compañía realizará una conferencia telefónica a las 1:30pm PT/4:30pm ET del mismo día. Los inversores pueden unirse a la llamada marcando +1-848-280-6550 y utilizando el código de acceso 'Avinger'. Una transmisión web en vivo estará disponible en la página de relaciones con los inversores de la empresa, y una repetición se publicará poco después de que concluya la llamada.
Avinger se especializa en la comercialización del primer y único sistema de catéter guiado por imágenes intravasculares para el diagnóstico y tratamiento de enfermedades vasculares.
Avinger Inc. (Nasdaq: AVGR)는 상장된 의료기기 회사로, 2024년 2분기 재무 결과를 2024년 8월 8일에 거래 종료 후 발표할 것이라고 발표했습니다. 회사는 같은 날 오후 1시 30분 PT/오후 4시 30분 ET에 컨퍼런스 콜을 진행할 예정입니다. 투자자들은 +1-848-280-6550으로 전화하여 'Avinger' 비밀번호를 사용해 전화를 통해 참여할 수 있습니다. 회사의 투자자 관계 페이지에서 생중계 웹캐스트가 제공되며, 통화가 끝난 후 곧바로 재생본이 게시될 것입니다.
Avinger는 혈관 질환의 진단 및 치료를 위한 최초이자 유일한 카테터 기반의 혈관 내 이미지 유도 시스템을 마케팅하는 데 전문화되어 있습니다.
Avinger Inc. (Nasdaq: AVGR), une entreprise de dispositifs médicaux en phase commerciale, a annoncé qu'elle publiera ses résultats financiers du deuxième trimestre 2024 le 8 août 2024, après la clôture des échanges. L'entreprise organisera une conférence téléphonique à 13h30 PT/16h30 ET le même jour. Les investisseurs peuvent participer à l'appel en composant le +1-848-280-6550 et en utilisant le code d'accès 'Avinger'. Un webinaire en direct sera disponible sur la page des relations avec les investisseurs de l'entreprise, et un enregistrement sera publié peu après la fin de l'appel.
Avinger se spécialise dans la commercialisation du premier et unique système par cathéter guidé par imagerie intravasculaire pour le diagnostic et le traitement des maladies vasculaires.
Avinger Inc. (Nasdaq: AVGR), ein Unternehmen für medizinische Geräte in der kommerziellen Phase, hat angekündigt, dass es am 8. August 2024, nach Börsenschluss, die Finanzergebnisse für das zweite Quartal 2024 veröffentlichen wird. Das Unternehmen wird am selben Tag um 13:30 Uhr PT/16:30 Uhr ET eine Telefonkonferenz einberufen. Investoren können sich unter +1-848-280-6550 einwählen und den Zugangscode 'Avinger' verwenden. Eine Live-Webcast wird auf der Investor Relations-Seite des Unternehmens verfügbar sein, und eine Wiederholung wird kurz nach dem Ende der Konferenz bereitgestellt.
Avinger ist darauf spezialisiert, das erste und einzige katheterbasiertes System zur bildgesteuerten Diagnose und Behandlung von Gefäßerkrankungen zu vermarkten.
- Timely financial reporting indicates transparency and compliance
- None.
REDWOOD CITY, CA / ACCESSWIRE / July 29, 2024 / Avinger, Inc. (Nasdaq:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of vascular disease, today announced that it will release its financial results for the second quarter 2024 after the close of trading on Thursday, August 8, 2024. The Company will host a conference call beginning at 1:30pm PT/4:30pm ET.
To join the call by telephone, please dial +1-848-280-6550 and use passcode Avinger. A live webcast of the conference call will be available online from the investor relations page of the Company's corporate website at www.avinger.com.
A replay of the webcast will be made available on Avinger's website, www.avinger.com, shortly after completion of the call.
About Avinger, Inc.
Avinger is a commercial-stage medical device company that designs and develops the first image-guided, catheter-based system for the diagnosis and treatment of patients with vascular disease in the peripheral and coronary arteries. Avinger is dedicated to radically changing the way vascular disease is treated through its Lumivascular platform, which currently consists of the Lightbox series of imaging consoles, the Ocelot and Tigereye® family of chronic total occlusion (CTO) catheters, and the Pantheris® family of atherectomy devices for the treatment of peripheral artery disease (PAD), estimated to affect more than 200 million people worldwide. Avinger is developing its first product application for the treatment of coronary artery disease (CAD), an image-guided system for CTO-crossing in the coronary arteries, which provides the opportunity to redefine a large and underserved market. Avinger is based in Redwood City, California. For more information, please visit www.avinger.com.
Follow Avinger on Twitter and Facebook.
Investor Contact:
Matt Kreps
Darrow Associates Investor Relations
(214) 597-8200
mkreps@darrowir.com
SOURCE: Avinger, Inc.
View the original press release on accesswire.com
FAQ
When will Avinger (AVGR) release its Q2 2024 financial results?
What time is Avinger's (AVGR) Q2 2024 earnings conference call?
How can investors join Avinger's (AVGR) Q2 2024 earnings call?
What does Avinger (AVGR) specialize in?
